SUNNYVALE, Calif., June 10, 2025 /PRNewswire/ -- In a major milestone for heart failure treatment, the first commercial patients in the U.S. have been successfully implanted with the FDA-approved ...
Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely. SUNNYVALE, Calif., April 17, 2025 /PRNewswire/ -- EBR Systems, Inc. (ASX: EBR) has received ...
SUNNYVALE, Calif., October 14, 2025--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing device for heart failure, today announced that Centers for Medicare & ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...
Totally leadless cardiac resynchronization therapy (CRT) combining the Micra transcatheter pacing system and a WiSE-CRT system was feasible and associated with significant acute QRS reduction in a ...
Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug Administration Approval and Commercialisation SUNNYVALE, Calif., May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results